CN104066497A - 具有亲水性涂层的多孔膜及其制备和使用方法 - Google Patents
具有亲水性涂层的多孔膜及其制备和使用方法 Download PDFInfo
- Publication number
- CN104066497A CN104066497A CN201280065407.1A CN201280065407A CN104066497A CN 104066497 A CN104066497 A CN 104066497A CN 201280065407 A CN201280065407 A CN 201280065407A CN 104066497 A CN104066497 A CN 104066497A
- Authority
- CN
- China
- Prior art keywords
- nitrocellulose filter
- perforated membrane
- film
- membrane
- immunoassays
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 134
- 238000000034 method Methods 0.000 title claims abstract description 72
- 238000000576 coating method Methods 0.000 title claims abstract description 56
- 239000011248 coating agent Substances 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title claims description 14
- 238000003018 immunoassay Methods 0.000 claims abstract description 59
- 230000009871 nonspecific binding Effects 0.000 claims abstract description 35
- 239000000463 material Substances 0.000 claims abstract description 29
- 229920001220 nitrocellulos Polymers 0.000 claims description 166
- 239000000020 Nitrocellulose Substances 0.000 claims description 165
- 238000006116 polymerization reaction Methods 0.000 claims description 42
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 36
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 36
- 238000010894 electron beam technology Methods 0.000 claims description 35
- 239000012472 biological sample Substances 0.000 claims description 30
- 229920001223 polyethylene glycol Polymers 0.000 claims description 28
- 239000002202 Polyethylene glycol Substances 0.000 claims description 27
- 239000000427 antigen Substances 0.000 claims description 23
- 102000004169 proteins and genes Human genes 0.000 claims description 23
- 102000036639 antigens Human genes 0.000 claims description 22
- 108091007433 antigens Proteins 0.000 claims description 22
- 229920000642 polymer Polymers 0.000 claims description 22
- 108090000623 proteins and genes Proteins 0.000 claims description 22
- 239000002981 blocking agent Substances 0.000 claims description 18
- 150000002433 hydrophilic molecules Chemical class 0.000 claims description 18
- 108091034057 RNA (poly(A)) Proteins 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 16
- 239000004094 surface-active agent Substances 0.000 claims description 15
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 13
- 239000010931 gold Substances 0.000 claims description 13
- 229910052737 gold Inorganic materials 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 239000000178 monomer Substances 0.000 claims description 10
- 210000004369 blood Anatomy 0.000 claims description 9
- 239000008280 blood Substances 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 9
- 210000002700 urine Anatomy 0.000 claims description 9
- 238000002965 ELISA Methods 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 201000010099 disease Diseases 0.000 claims description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- 108020004707 nucleic acids Proteins 0.000 claims description 8
- 102000039446 nucleic acids Human genes 0.000 claims description 8
- 150000007523 nucleic acids Chemical class 0.000 claims description 8
- -1 polypropylene Polymers 0.000 claims description 8
- 210000004027 cell Anatomy 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- 210000003296 saliva Anatomy 0.000 claims description 7
- 210000001519 tissue Anatomy 0.000 claims description 7
- 210000000416 exudates and transudate Anatomy 0.000 claims description 6
- 230000006872 improvement Effects 0.000 claims description 6
- 125000003010 ionic group Chemical group 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 5
- 210000002751 lymph Anatomy 0.000 claims description 5
- 238000003127 radioimmunoassay Methods 0.000 claims description 5
- 230000036039 immunity Effects 0.000 claims description 4
- 210000003097 mucus Anatomy 0.000 claims description 4
- 239000012857 radioactive material Substances 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 241001044369 Amphion Species 0.000 claims description 3
- 239000004677 Nylon Substances 0.000 claims description 3
- 239000002033 PVDF binder Substances 0.000 claims description 3
- 239000004698 Polyethylene Substances 0.000 claims description 3
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 3
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002301 cellulose acetate Polymers 0.000 claims description 3
- 239000005556 hormone Substances 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 229920001778 nylon Polymers 0.000 claims description 3
- 239000004417 polycarbonate Substances 0.000 claims description 3
- 229920000515 polycarbonate Polymers 0.000 claims description 3
- 229920006267 polyester film Polymers 0.000 claims description 3
- 229920006393 polyether sulfone Polymers 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 229920000098 polyolefin Polymers 0.000 claims description 3
- 229920006380 polyphenylene oxide Polymers 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- 229920006264 polyurethane film Polymers 0.000 claims description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 3
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 3
- 239000004627 regenerated cellulose Substances 0.000 claims description 3
- 230000008439 repair process Effects 0.000 claims description 3
- 208000031888 Mycoses Diseases 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 claims description 2
- 239000007850 fluorescent dye Substances 0.000 claims description 2
- 230000004217 heart function Effects 0.000 claims description 2
- 208000010125 myocardial infarction Diseases 0.000 claims description 2
- 230000005855 radiation Effects 0.000 claims description 2
- 230000003612 virological effect Effects 0.000 claims description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims 2
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical class C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 claims 2
- 125000001931 aliphatic group Chemical group 0.000 claims 2
- 125000000746 allylic group Chemical group 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 150000002390 heteroarenes Chemical class 0.000 claims 2
- UCUUFSAXZMGPGH-UHFFFAOYSA-N penta-1,4-dien-3-one Chemical compound C=CC(=O)C=C UCUUFSAXZMGPGH-UHFFFAOYSA-N 0.000 claims 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 2
- 229920002554 vinyl polymer Polymers 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 abstract description 7
- 238000000338 in vitro Methods 0.000 abstract description 7
- 238000012123 point-of-care testing Methods 0.000 abstract description 2
- 230000007423 decrease Effects 0.000 abstract 1
- 230000004048 modification Effects 0.000 description 27
- 238000012986 modification Methods 0.000 description 27
- 238000012360 testing method Methods 0.000 description 24
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 18
- 239000012146 running buffer Substances 0.000 description 13
- 229920002477 rna polymer Polymers 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 11
- 238000007385 chemical modification Methods 0.000 description 8
- 229920000671 polyethylene glycol diacrylate Polymers 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 239000012491 analyte Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 5
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 5
- 239000007790 solid phase Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 230000027455 binding Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000006184 cosolvent Substances 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 238000007598 dipping method Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 241000606161 Chlamydia Species 0.000 description 2
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 2
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 2
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 229920000578 graft copolymer Polymers 0.000 description 2
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
- IHDBZCJYSHDCKF-UHFFFAOYSA-N 4,6-dichlorotriazine Chemical compound ClC1=CC(Cl)=NN=N1 IHDBZCJYSHDCKF-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 238000004483 ATR-FTIR spectroscopy Methods 0.000 description 1
- 108010000239 Aequorin Proteins 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 208000013875 Heart injury Diseases 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 1
- 125000004386 diacrylate group Chemical group 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000007046 ethoxylation reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 102000027450 oncoproteins Human genes 0.000 description 1
- 108091008819 oncoproteins Proteins 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B3/00—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form
- B32B3/26—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form characterised by a particular shape of the outline of the cross-section of a continuous layer; characterised by a layer with cavities or internal voids ; characterised by an apertured layer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/249921—Web or sheet containing structurally defined element or component
- Y10T428/249953—Composite having voids in a component [e.g., porous, cellular, etc.]
- Y10T428/249987—With nonvoid component of specified composition
- Y10T428/249991—Synthetic resin or natural rubbers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (48)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/340793 | 2011-12-30 | ||
US13/340,793 US20130171669A1 (en) | 2011-12-30 | 2011-12-30 | Porous membranes having a hydrophilic coating and methods for their preparation and use |
US13/362793 | 2012-01-31 | ||
US13/362,793 US20130171619A1 (en) | 2011-12-30 | 2012-01-31 | Porous membranes having a hydrophilic coating and methods for their preparation and use |
PCT/US2012/071696 WO2013101857A1 (en) | 2011-12-30 | 2012-12-27 | Porous membranes having a hydrophilic coating and methods for their preparation and use |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104066497A true CN104066497A (zh) | 2014-09-24 |
CN104066497B CN104066497B (zh) | 2016-12-28 |
Family
ID=48695090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280065407.1A Active CN104066497B (zh) | 2011-12-30 | 2012-12-27 | 具有亲水性涂层的多孔膜及其制备和使用方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20130171619A1 (zh) |
EP (1) | EP2797679B1 (zh) |
CN (1) | CN104066497B (zh) |
WO (1) | WO2013101857A1 (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105440300A (zh) * | 2015-12-01 | 2016-03-30 | 中国石油大学(华东) | 一种亲水改性聚苯乙烯材料表面的有效方法 |
CN106397805A (zh) * | 2015-03-31 | 2017-02-15 | 帕尔公司 | 亲水改性的氟化薄膜 |
CN107441965A (zh) * | 2017-08-11 | 2017-12-08 | 杭州科百特过滤器材有限公司 | 一种多孔膜的制备方法 |
CN108946933A (zh) * | 2018-08-03 | 2018-12-07 | 南京高新工大生物技术研究院有限公司 | 一种改性聚乙烯微生物载体填料 |
CN111351781A (zh) * | 2018-12-20 | 2020-06-30 | 麦德龙生物株式会社 | 电化学发光分析装置和使用其分析样品的方法 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102140938B1 (ko) | 2012-09-07 | 2020-08-04 | 고쿠리츠켄큐카이하츠호진 카가쿠기쥬츠신코키코 | 유기 중합 박막과 그 제조방법 |
US20150167065A1 (en) * | 2013-12-13 | 2015-06-18 | General Electric Company | Isothermal amplification of nucleic acids within a porous matrix |
US11754563B2 (en) | 2014-11-20 | 2023-09-12 | Global Life Sciences Solutions Operations UK Ltd | Porous membranes with a polymer grafting, methods and uses thereof |
US9861939B2 (en) * | 2015-10-02 | 2018-01-09 | Lawrence Livermore National Security, Llc | Filtration device for rapid separation of biological particles from complex matrices |
EP3803321A4 (en) * | 2018-05-30 | 2022-01-19 | University Of South Australia | DEVICES AND METHODS FOR COLLECTING AND STORING LIQUID SAMPLES FOR ANALYSIS |
CN109395616B (zh) * | 2018-12-10 | 2021-03-09 | 天津工业大学 | 一种核孔蛋白接枝均孔聚碳酸酯仿生蛋白传输膜的制备方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070272607A1 (en) * | 2006-05-24 | 2007-11-29 | Millipore Corporation | Membrane surface modification by radiation-induced polymerization |
US20080200434A1 (en) * | 2006-09-14 | 2008-08-21 | Daniloff George Y | Chemical Target-Binding Compositions |
US20090188857A1 (en) * | 2008-01-25 | 2009-07-30 | General Electric Company | Permanent hydrophilic porous coatings and methods of making them |
US20090208975A1 (en) * | 2007-12-13 | 2009-08-20 | Beckman Coulter, Inc. | Device and methods for detecting a target cell |
CN101797482A (zh) * | 2008-12-05 | 2010-08-11 | 通用电气公司 | 不对称复合膜的制备方法 |
CN101945694A (zh) * | 2007-12-27 | 2011-01-12 | 3M创新有限公司 | 制备官能化膜的方法 |
US20110147308A1 (en) * | 2009-12-21 | 2011-06-23 | Siemens Water Technologies Corp. | Charged Porous Polymeric Membranes and Their Preparation |
CN104136106A (zh) * | 2011-12-29 | 2014-11-05 | 通用电气公司 | 具有聚合涂层的多孔膜及其制备和使用方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4094647A (en) | 1976-07-02 | 1978-06-13 | Thyroid Diagnostics, Inc. | Test device |
NL7807532A (nl) | 1978-07-13 | 1980-01-15 | Akzo Nv | Metaal-immunotest. |
US5073484A (en) | 1982-03-09 | 1991-12-17 | Bio-Metric Systems, Inc. | Quantitative analysis apparatus and method |
US5514602A (en) | 1986-06-09 | 1996-05-07 | Ortho Diagnostic Systems, Inc. | Method of producing a metal sol reagent containing colloidal metal particles |
CA1303983C (en) | 1987-03-27 | 1992-06-23 | Robert W. Rosenstein | Solid phase assay |
US4857453A (en) | 1987-04-07 | 1989-08-15 | Syntex (U.S.A.) Inc. | Immunoassay device |
JPH0746107B2 (ja) | 1987-04-27 | 1995-05-17 | ユニリーバー・ナームローゼ・ベンノートシヤープ | 検定法 |
US5120643A (en) | 1987-07-13 | 1992-06-09 | Abbott Laboratories | Process for immunochromatography with colloidal particles |
AU2684488A (en) | 1988-06-27 | 1990-01-04 | Carter-Wallace, Inc. | Test device and method for colored particle immunoassay |
US6352862B1 (en) | 1989-02-17 | 2002-03-05 | Unilever Patent Holdings B.V. | Analytical test device for imuno assays and methods of using same |
US5252496A (en) | 1989-12-18 | 1993-10-12 | Princeton Biomeditech Corporation | Carbon black immunochemical label |
US5049275A (en) * | 1990-06-15 | 1991-09-17 | Hoechst Celanese Corp. | Modified microporous structures |
US20030186311A1 (en) * | 1999-05-21 | 2003-10-02 | Bioforce Nanosciences, Inc. | Parallel analysis of molecular interactions |
US20110065126A1 (en) * | 2008-03-26 | 2011-03-17 | Riken | Substance-immobilizing substrate, substance-immobilized subtrate, and analysis method |
KR101327297B1 (ko) * | 2008-06-12 | 2013-11-11 | 잇판자이단호진 가와무라 리카가쿠 겐큐쇼 | 유기무기 복합체 분산액 및 그것을 사용하여 제조되는 세포 배양 기재, 및 그들의 제조 방법 |
-
2012
- 2012-01-31 US US13/362,793 patent/US20130171619A1/en not_active Abandoned
- 2012-12-27 CN CN201280065407.1A patent/CN104066497B/zh active Active
- 2012-12-27 WO PCT/US2012/071696 patent/WO2013101857A1/en active Application Filing
- 2012-12-27 EP EP12862319.6A patent/EP2797679B1/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070272607A1 (en) * | 2006-05-24 | 2007-11-29 | Millipore Corporation | Membrane surface modification by radiation-induced polymerization |
US20080200434A1 (en) * | 2006-09-14 | 2008-08-21 | Daniloff George Y | Chemical Target-Binding Compositions |
US20090208975A1 (en) * | 2007-12-13 | 2009-08-20 | Beckman Coulter, Inc. | Device and methods for detecting a target cell |
CN101945694A (zh) * | 2007-12-27 | 2011-01-12 | 3M创新有限公司 | 制备官能化膜的方法 |
US20090188857A1 (en) * | 2008-01-25 | 2009-07-30 | General Electric Company | Permanent hydrophilic porous coatings and methods of making them |
CN101797482A (zh) * | 2008-12-05 | 2010-08-11 | 通用电气公司 | 不对称复合膜的制备方法 |
US20110147308A1 (en) * | 2009-12-21 | 2011-06-23 | Siemens Water Technologies Corp. | Charged Porous Polymeric Membranes and Their Preparation |
CN104136106A (zh) * | 2011-12-29 | 2014-11-05 | 通用电气公司 | 具有聚合涂层的多孔膜及其制备和使用方法 |
Non-Patent Citations (1)
Title |
---|
PAUL T. CHARLES等: "Reduction of Non-Specific Protein Adsorption Using Poly(ethylene) Glycol (PEG) Modified Polyacrylate Hydrogels In Immunoassays for Staphylococcal Enterotoxin B Detection", 《SENSORS》, vol. 9, no. 1, 23 January 2009 (2009-01-23), pages 645 - 655, XP 055137760, DOI: doi:10.3390/s90100645 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106397805A (zh) * | 2015-03-31 | 2017-02-15 | 帕尔公司 | 亲水改性的氟化薄膜 |
CN106397805B (zh) * | 2015-03-31 | 2019-02-01 | 帕尔公司 | 亲水改性的氟化薄膜 |
CN105440300A (zh) * | 2015-12-01 | 2016-03-30 | 中国石油大学(华东) | 一种亲水改性聚苯乙烯材料表面的有效方法 |
CN107441965A (zh) * | 2017-08-11 | 2017-12-08 | 杭州科百特过滤器材有限公司 | 一种多孔膜的制备方法 |
CN108946933A (zh) * | 2018-08-03 | 2018-12-07 | 南京高新工大生物技术研究院有限公司 | 一种改性聚乙烯微生物载体填料 |
CN111351781A (zh) * | 2018-12-20 | 2020-06-30 | 麦德龙生物株式会社 | 电化学发光分析装置和使用其分析样品的方法 |
CN111351781B (zh) * | 2018-12-20 | 2023-11-24 | 麦德龙生物株式会社 | 电化学发光分析装置和使用其分析样品的方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2013101857A1 (en) | 2013-07-04 |
EP2797679B1 (en) | 2018-02-28 |
EP2797679A1 (en) | 2014-11-05 |
EP2797679A4 (en) | 2015-09-23 |
CN104066497B (zh) | 2016-12-28 |
US20130171619A1 (en) | 2013-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104066497A (zh) | 具有亲水性涂层的多孔膜及其制备和使用方法 | |
US7855068B2 (en) | Methods and kits for detecting a target cell | |
AU2014226173B2 (en) | Method and device for combined detection of viral and bacterial infections | |
CN104136106A (zh) | 具有聚合涂层的多孔膜及其制备和使用方法 | |
US10379121B2 (en) | Method and device for combined detection of viral and bacterial infections | |
EP3458854B1 (en) | Method and kit for capturing extracellular vesicles (evs) on a solid surface | |
US20220146502A1 (en) | High-sensitivity assay | |
US10379119B2 (en) | Synthetic thread based lateral flow immunoassay | |
US20130171026A1 (en) | Porous membranes having a polymeric coating and methods for their preparation and use | |
US20120276656A1 (en) | Multiplexed Assay Methods | |
US20100047766A1 (en) | Analyte manipulation and detection | |
CN107003306A (zh) | 具有聚合物接枝的多孔薄膜、其方法及用途 | |
US11754563B2 (en) | Porous membranes with a polymer grafting, methods and uses thereof | |
JP6832160B2 (ja) | 多重分析法を実行するための対照 | |
CN110168366A (zh) | 用于基于颗粒的生物测定的过筛垂直流系统 | |
US20130171618A1 (en) | Porous membranes having a polymeric coating and methods for their preparation and use | |
US20230221319A1 (en) | A Method, A System, An Article, A Kit And Use Thereof For Biomolecule, Bioorganelle, Bioparticle, Cell And Microorganism Detection | |
US20130171368A1 (en) | Porous membranes having a polymeric coating and methods for their preparation and use | |
US20210389315A1 (en) | Point of care device for early and rapid disease diagnosis | |
RU2818001C1 (ru) | Способ повышения чувствительности мультиплексного иммунохроматографического анализа | |
CN116819058A (zh) | 一种分析流体样本细胞外囊泡聚糖的方法及其装置和应用 | |
US10365284B2 (en) | Kit for detecting target material and method of detecting target material using the same | |
US7195867B2 (en) | Method for detection of multiple test materials in a sample | |
WO2021259406A1 (de) | Verfahren, verwendung des verfahrens sowie kit zum nachweis von bioindikatoren in einer probe | |
JP2021018177A (ja) | 分析デバイス |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210825 Address after: England Patentee after: Global life science solutions UK Ltd. Address before: Buckinghamshire Patentee before: GE HEALTHCARE UK Ltd. Effective date of registration: 20210825 Address after: Buckinghamshire Patentee after: GE HEALTHCARE UK Ltd. Address before: New York State, USA Patentee before: General Electric Co. |